Matrix metalloproteinase-9 -1562 C/T polymorphism is associated with the risk of sepsis in a Chinese population: A

Cuijuan Zheng1, Jiayu Wang1, Shouxiang Xie2

  • 1Department of Anaesthesiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, China.

Innate Immunity
|February 17, 2021
PubMed

Insights

The MMP-9 -1562 C/T gene variant increases sepsis risk, particularly in smokers. This polymorphism is linked to lower MMP-9 levels and sepsis mortality, suggesting its potential as a diagnostic marker.

Area of Science:

  • Genetics
  • Molecular Biology
  • Critical Care Medicine

Background:

  • Matrix metalloproteinase-9 (MMP-9) plays a role in sepsis pathogenesis.
  • Genetic variations in MMP-9 may influence sepsis susceptibility and outcomes.

Purpose of the Study:

  • To investigate the association between the MMP-9 -1562 C/T polymorphism and sepsis risk in the Han Chinese population.
  • To explore the relationship between this polymorphism, MMP-9 serum levels, and sepsis mortality.

Main Methods:

  • Genotyping of 312 sepsis patients and 413 controls using PCR restriction fragment length polymorphism.
  • Analysis of MMP-9 serum levels and correlation with genotype.
  • Assessment of sepsis risk and mortality in relation to the MMP-9 polymorphism.

Main Results:

  • The MMP-9 -1562 C/T polymorphism was significantly associated with increased sepsis risk (OR=1.45-1.49).
  • This association was more pronounced in smokers, drinkers, females, and overweight individuals.
  • The polymorphism correlated with lower MMP-9 serum levels and increased sepsis mortality. Smoking combined with the CT genotype heightened sepsis risk.

Conclusions:

  • The MMP-9 -1562 C/T polymorphism is a risk factor for sepsis in Han Chinese, especially when interacting with smoking.
  • This genetic variant may serve as a potential biomarker for sepsis diagnosis and prognosis.